Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13312-80-6

Post Buying Request

13312-80-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13312-80-6 Usage

General Description

Hydroxy(4-nitrophenyl)acetonitrile, also known as 4-nitrobenzyl cyanide, is a chemical compound with the formula C8H6N2O3. It is a pale yellow solid that is slightly soluble in water and has a characteristic nitro aromatic odor. hydroxy(4-nitrophenyl)acetonitrile is used as an intermediate in the synthesis of various organic compounds and pharmaceuticals. It is a versatile building block in organic chemistry, often utilized in the preparation of other important molecules. Additionally, hydroxy(4-nitrophenyl)acetonitrile is also employed as a reagent in biochemical and chemical research, particularly in the synthesis of pharmaceutical and agrochemical products. However, it is important to handle this compound with care, as it can be potentially hazardous if not used properly.

Check Digit Verification of cas no

The CAS Registry Mumber 13312-80-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,3,1 and 2 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 13312-80:
(7*1)+(6*3)+(5*3)+(4*1)+(3*2)+(2*8)+(1*0)=66
66 % 10 = 6
So 13312-80-6 is a valid CAS Registry Number.

13312-80-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-hydroxy-2-(4-nitrophenyl)acetonitrile

1.2 Other means of identification

Product number -
Other names 2-hydroxy-2-(p-nitrophenyl)acetonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13312-80-6 SDS

13312-80-6Relevant articles and documents

Highly chemoselective and efficient Strecker reaction of aldehydes with TMSCN catalyzed by MgI2 etherate under solvent-free conditions

He, Kailun,Liu, Huijun,Zhang, Xingxian,Zhou, Jing

supporting information, p. 933 - 936 (2019/03/08)

Strecker reaction of various substituted aromatic aldehydes, heteroaromatic aldehydes, aliphatic aldehydes and α,β-unsaturated aldehydes with trimethylsilyl cyanide (TMSCN) was realized in the presence of 5 mol % of MgI2 etherate in a mild, efficient and highly chemoselective manner under solvent-free conditions.

SELF-IMMOLATIVE LINKERS CONTAINING MANDELIC ACID DERIVATIVES, DRUG-LIGAND CONJUGATES FOR TARGETED THERAPIES AND USES THEREOF

-

Page/Page column 54; 94, (2015/03/28)

The invention provides a therapeutic drug and targeting conjugate, pharmaceutical compositions containing these conjugates in pharmaceutical composition, and uses of these conjugates in anti-neoplastic and other therapeutic regimens. Also provided are novel intermediates thereof. The conjugates provide a therapeutic drug fragment or prodrug fragment bound to a targeting moiety via a linker which comprises a substrate cleavable by a protease such as Cathepsin B. The targeting moiety is a ligand which targets a cell surface molecule, such as a cell surface receptor on an anti-neoplastic cell. The ligand may function solely as a targeting moiety or may itself have a therapeutic effect. Following administration of the therapeutic drug and targeting conjugate of formula I and exposure of the conjugate to the protease specific for the substrate, the linker is cleaved and the targeting moiety is separated from the conjugate, which causes the drug fragment or prodrug fragment to convert to the drug or prodrug. The recited conjugates are useful in anti-neoplastic therapies. Also provided are methods of making the therapeutic drug and targeting conjugates and intermediates thereof, and kits comprising the therapeutic drug and targeting conjugates.

Three-Dimensional Heterometallic Coordination Networks: Syntheses, Crystal Structures, Topologies, and Heterogeneous Catalysis

Srivastava, Sumit,Aggarwal, Himanshu,Gupta, Rajeev

, p. 4110 - 4122 (2015/08/18)

This work presents the synthesis of {Co3+-Zn2+} and {Co3+-Cd2+} heterometallic coordination networks. These networks are originated from two unique Co3+-based metalloligands containing appended arylcarboxylic acid groups at the strategically placed positions. Such appended arylcarboxylate groups coordinate the secondary metal ions, Zn2+ and Cd2+, to afford distinct three-dimensional networks. All four networks display orderly arrangement of secondary metal ions and unique network topologies including an unprecedented one. These networks have been shown to act as the heterogeneous and reusable catalysts for the Knoevenagel condensation reactions and cyanation reactions of assorted aldehydes. Cyanation reactions nicely demonstrate the substrate size-exclusion catalysis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13312-80-6